Lifestyle Advice to Patients with Bladder Cancer: A National Survey of Dutch Urologists

Overview

Journal Bladder Cancer

Publisher IOS Press

Date 2024 Nov 4

PMID 39493821

Authors

Ivy Beeren

Carlos Koops

Antoine G van der Heijden

Katja K H Aben

Lambertus A L M Kiemeney

J Alfred Witjes

Alina Vrieling

Affiliations

Soon will be listed here.

Abstract

Background: Not much is known about the extent to which urologists discuss lifestyle with patients with bladder cancer (BC), despite patients considering urologists as an important source of information and motivation.

Objective: To determine how often lifestyle is asked about, advised on, and referred for by Dutch urologists to patients with BC, as well as to evaluate urologists' perceptions and barriers.

Methods: An anonymous online survey was sent to Dutch urologists. The survey included questions on demographics, awareness of guidelines, clinical practice (asking about, advising on, and referring for lifestyle), perceptions, and barriers with regard to smoking, body weight, physical activity, diet, alcohol consumption, and fluid intake.

Results: Most of the 49 respondents were male, affiliated with a non-academic hospital, and had over 10 years of experience. Smoking appeared to be the only lifestyle factor that patients are advised on, with 90% of urologists advising > 75% of their patients. Advice on other lifestyle factors was far less common, with 63-92% of urologists giving < 50% of their patients advice. Referral rates were low for all lifestyle factors. Lifestyle advice was generally perceived as (very) important. Almost all respondents reported one or more barriers in giving lifestyle advice. A lack of time and a perceived lack of patient interest and motivation were reported most.

Conclusions: Apart from advice on smoking cessation, lifestyle advice is not frequently provided by urologists to patients with BC. Although urologists perceive lifestyle as important, they report several barriers to providing lifestyle advice and referring patients.

References

Massoud M, Ikdais W, Zeghondy J, Saad A . Provision of Lifestyle Recommendations to Cancer Patients: Results of a Nationally Representative Survey of Hematologists/Oncologists. J Cancer Educ. 2020; 36(4):702-709. DOI: 10.1007/s13187-020-01691-8. View

Pallin N, Beeken R, Jones K, Woznitza N, Fisher A . A Survey of Therapeutic Radiographers' Knowledge, Practices, and Barriers in Delivering Health Behaviour Advice to Cancer Patients. J Cancer Educ. 2020; 37(4):890-897. PMC: 9399055. DOI: 10.1007/s13187-020-01896-x. View

Winters B, Wen L, Holt S, Dash A, Gore J, Schade G . Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes Survey. J Urol. 2019; 202(2):241-246. DOI: 10.1097/JU.0000000000000206. View

Day F, Sherwood E, Chen T, Barbouttis M, Varlow M, Martin J . Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists. Asia Pac J Clin Oncol. 2018; 14(6):431-438. DOI: 10.1111/ajco.12876. View

Witjes J, Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou J . European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2023; 85(1):17-31. DOI: 10.1016/j.eururo.2023.08.016. View

van Osch F, Jochems S, Reulen R, Pirrie S, Nekeman D, Wesselius A . The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study. Cancer Causes Control. 2018; 29(7):675-683. PMC: 5999150. DOI: 10.1007/s10552-018-1046-8. View

Solans M, Chan D, Mitrou P, Norat T, Romaguera D . A systematic review and meta-analysis of the 2007 WCRF/AICR score in relation to cancer-related health outcomes. Ann Oncol. 2020; 31(3):352-368. DOI: 10.1016/j.annonc.2020.01.001. View

van Osch F, Jochems S, van Schooten F, Bryan R, Zeegers M . Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis. J Urol. 2015; 195(4 Pt 1):872-9. DOI: 10.1016/j.juro.2015.10.139. View

Bassett J, Gore J, Kwan L, Ritch C, Barocas D, Penson D . Knowledge of the harms of tobacco use among patients with bladder cancer. Cancer. 2014; 120(24):3914-22. DOI: 10.1002/cncr.28915. View

10.

Ramsey I, Chan A, Charalambous A, Cheung Y, Darling H, Eng L . Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners' knowledge, practices, barriers, and facilitators. Support Care Cancer. 2022; 30(11):9379-9391. PMC: 9521001. DOI: 10.1007/s00520-022-07342-6. View

11.

Goeij L, Westhoff E, Witjes J, Aben K, Kampman E, Kiemeney L . The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life. BMJ Open. 2019; 9(10):e030396. PMC: 6797314. DOI: 10.1136/bmjopen-2019-030396. View

12.

Malcomson F, Parra-Soto S, Ho F, Lu L, Celis-Morales C, Sharp L . Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study. BMC Med. 2023; 21(1):407. PMC: 10683228. DOI: 10.1186/s12916-023-03107-y. View

13.

Matulewicz R, Meeks W, Mbassa R, Fang R, Pittman A, Mossanen M . Urologists' Perceptions and Practices Related to Patient Smoking and Cessation: A National Assessment From the 2021 American Urological Association Census. Urology. 2023; 180:14-20. PMC: 10592412. DOI: 10.1016/j.urology.2023.06.022. View

14.

Westhoff E, Kampman E, Aben K, Hendriks I, Witjes J, Kiemeney L . Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients. Urol Oncol. 2019; 37(9):573.e1-573.e8. DOI: 10.1016/j.urolonc.2019.04.016. View

15.

Chandi J, Soundararajan S, Bukowski W, Britt W, Weiss K, Matulewicz R . Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors. Bladder Cancer. 2024; 10(1):61-69. PMC: 11192552. DOI: 10.3233/BLC-230093. View

16.

Catto J, Rogers Z, Downing A, Mason S, Jubber I, Bottomley S . Lifestyle Factors in Patients with Bladder Cancer: A Contemporary Picture of Tobacco Smoking, Electronic Cigarette Use, Body Mass Index, and Levels of Physical Activity. Eur Urol Focus. 2023; 9(6):974-982. DOI: 10.1016/j.euf.2023.04.003. View

17.

Ripping T, Kiemeney L, van Hoogstraten L, Witjes J, Aben K . Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB). BMC Cancer. 2020; 20(1):455. PMC: 7240996. DOI: 10.1186/s12885-020-06954-7. View

18.

Westhoff E, Witjes J, Fleshner N, Lerner S, Shariat S, Steineck G . Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis. Bladder Cancer. 2018; 4(1):91-112. PMC: 5798521. DOI: 10.3233/BLC-170147. View

19.

Babjuk M, Burger M, Capoun O, Cohen D, Comperat E, Dominguez Escrig J . European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2021; 81(1):75-94. DOI: 10.1016/j.eururo.2021.08.010. View

20.

Warren G, Marshall J, Cummings K, Toll B, Gritz E, Hutson A . Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013; 9(5):258-62. PMC: 3770508. DOI: 10.1200/JOP.2013.001025. View